Association of polymorphisms in CYP17A1, MTP, and VLDLR with bone mineral density in community-dwelling Japanese women and men

Kanis, 1994, The diagnosis of osteoporosis, J. Bone Miner. Res., 9, 1137, 10.1002/jbmr.5650090802 Pocock, 1987, Genetic determinations of bone mass in adults: a twin study, J. Clin. Invest., 80, 706, 10.1172/JCI113125 Gueguen, 1995, Segregation analysis and variance components analysis of bone mineral density in healthy families, J. Bone Miner. Res., 10, 2017, 10.1002/jbmr.5650101223 Howard, 1998, Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study, J. Bone Miner. Res., 13, 1318, 10.1359/jbmr.1998.13.8.1318 Johnson, 1997, Linkage of a gene causing high bone mass to human chromosome 11 (11q12–13), Am. J. Hum. Genet., 60, 1326, 10.1086/515470 Econs, 2004, Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women, Am. J. Hum. Genet., 74, 223, 10.1086/381401 Morrison, 1994, Prediction of bone density from vitamin D receptor alleles, Nature, 367, 284, 10.1038/367284a0 Uitterlinden, 1998, Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women, N. Engl. J. Med., 338, 1016, 10.1056/NEJM199804093381502 Yamada, 2001, Transforming growth factor-β1 gene polymorphism and bone mineral density, JAMA, 285, 167, 10.1001/jama.285.2.167 Ioannidis, 2004, Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes, JAMA, 292, 2105, 10.1001/jama.292.17.2105 Auchus, 1999, Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations, Mol. Endocrinol., 13, 1169, 10.1210/me.13.7.1169 Yanase, 1991, 17 Alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition, Endocr. Rev., 12, 91, 10.1210/edrv-12-1-91 Carey, 1994, Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17, Hum. Mol. Genet., 3, 1873, 10.1093/hmg/3.10.1873 Kristensen, 1999, CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1, Cancer Res., 59, 2825 Lin, 2001, NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells, Mol. Endocrinol., 15, 1277, 10.1210/me.15.8.1277 Zmuda, 2001, A common promoter variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability of testosterone levels and bone size in men, J. Bone Miner. Res., 16, 911, 10.1359/jbmr.2001.16.5.911 Somner, 2004, Polymorphisms in the P450 c17 (17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women, J. Clin. Endocrinol. Metab., 89, 344, 10.1210/jc.2003-030164 Tofteng, 2004, Two single nucleotide polymorphisms in the CYP17 and COMT genes—relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study, Calcif. Tissue Int., 75, 123, 10.1007/s00223-004-0176-z Bergman, 1996, Age-related changes in osteogenic stem cells in mice, J. Bone Miner. Res., 11, 568, 10.1002/jbmr.5650110504 Parhami, 1999, Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells, J. Bone Miner. Res., 14, 2067, 10.1359/jbmr.1999.14.12.2067 Diascro, 1998, High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells, J. Bone Miner. Res., 13, 96, 10.1359/jbmr.1998.13.1.96 McFarlane, 2002, Pleiotropic effects of statins: lipid reduction and beyond, J. Clin. Endocrinol. Metab., 87, 1451, 10.1210/jc.87.4.1451 Orozco, 2004, Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women, Eur. J. Epidemiol., 19, 1105, 10.1007/s10654-004-1706-8 Poli, 2003, Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women, Obstet. Gynecol., 102, 922, 10.1016/j.obstetgynecol.2003.07.004 Gordon, 1995, Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles, Trends Cell Biol., 5, 317, 10.1016/S0962-8924(00)89054-6 Sharp, 1993, Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia, Nature, 365, 65, 10.1038/365065a0 Ledmyr, 2002, Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index, J. Lipid Res., 43, 51, 10.1016/S0022-2275(20)30186-3 Karpe, 1998, A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels, Arterioscler. Thromb. Vasc. Biol., 18, 756, 10.1161/01.ATV.18.5.756 Ledmyr, 2004, The microsomal triglyceride transfer protein gene −493 T variant lowers cholesterol but increases the risk of coronary heart disease, Circulation, 109, 2279, 10.1161/01.CIR.0000130070.96758.7b Geesaman, 2003, Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan, Proc. Natl. Acad. Sci. USA, 100, 14115, 10.1073/pnas.1936249100 Takahashi, 1992, Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity, Proc. Natl. Acad. Sci. USA, 89, 9252, 10.1073/pnas.89.19.9252 Sakai, 1994, Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene, J. Biol. Chem., 269, 2173, 10.1016/S0021-9258(17)42151-X Helbecque, 1997, The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans, Arterioscler. Thromb. Vasc. Biol., 17, 2759, 10.1161/01.ATV.17.11.2759 Okuizumi, 1995, Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease, Nat. Genet., 11, 207, 10.1038/ng1095-207 Feigelson, 1997, A polymorphism in the CYP17 gene increases the risk of breast cancer, Cancer Res., 57, 1063 Spurdle, 2000, CYP17 promoter polymorphism and breast cancer in Australian women under age forty years, J. Natl. Cancer Inst., 92, 1674, 10.1093/jnci/92.20.1674 Feigelson, 1998, Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations, Cancer Res., 58, 585 Haiman, 1999, The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer, Cancer Res., 59, 1015 Feigelson, 1999, Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy, Cancer Res., 59, 3908 Riggs, 2002, Sex steroids and the construction and conservation of the adult skeleton, Endocr. Rev., 23, 279, 10.1210/er.23.3.279 Couture, 2000, Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study, Atherosclerosis, 148, 337, 10.1016/S0021-9150(99)00281-6 Juo, 2000, Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, apoB, and triglyceride levels in young African American men: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study, Arterioscler. Thromb. Vasc. Biol., 20, 1316, 10.1161/01.ATV.20.5.1316 St-Pierre, 2002, Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein −493G/T polymorphism on plasma lipoprotein levels in men, Atherosclerosis, 160, 317, 10.1016/S0021-9150(01)00589-5 Takahashi, 2004, The very low-density lipoprotein (VLDL) receptor: characterization and function as a peripheral lipoprotein receptor, J. Atheroscler. Thromb., 11, 200, 10.5551/jat.11.200 Frykman, 1995, Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor, Proc. Natl. Acad. Sci. USA, 92, 8453, 10.1073/pnas.92.18.8453 Helbecque, 2001, VLDL receptor polymorphism, cognitive impairment, and dementia, Neurology, 56, 1183, 10.1212/WNL.56.9.1183 Shimokata, 2000, A new comprehensive study on aging—the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS–LSA), J. Epidemiol., 10, S1, 10.2188/jea.10.1sup_1 Yamada, 2003, Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men, J. Clin. Endocrinol. Metab., 88, 3372, 10.1210/jc.2002-021449 Yamada, 2005, Association of polymorphisms of androgen receptor and klotho genes with bone mineral density in Japanese women, J. Mol. Med., 83, 50, 10.1007/s00109-004-0578-4 Yamada, 2002, Prediction of the risk of myocardial infarction from polymorphisms in candidate genes, N. Engl. J. Med., 347, 1916, 10.1056/NEJMoa021445